Navigation Links
Two New Drugs For Breast Cancer Show Promise

Two of the most promising breast cancer drugs are raloxifene and lapatinib, according to researchers who revealed their findings// at he European Breast Cancer Conference (EBCC-5). Raloxifene is a drug that was first developed to treat osteoporosis in women.

It belongs to a class of drugs called selective benzothiophene oestrogen receptor modulator (SERM) and exerts an anti-estrogen effect. Hence it's use in breast cancer. In the trials where raloxifene was used as an osteoporosis drug, it also appeared to prevent the formation of new hormone dependant breast cancers. The MORE (The Multiple Outcomes of Raloxifene Evaluation) study, which evaluated 7,705 women by either administering raloxifene or placebo to a group. The results of this trial are awaited. Another trial that aims to test the efficacy of raloxifene was conducted on 20,000 postmenopausal women in the US. The results of this trial are also awaited. However, women taking raloxifene are known to have an increased risk of developing deep vein thrombosis or pulmonary embolism as side effects. Another drug that is exciting researchers is lapatinib, which is given orally. The molecule is a subset of Epidermal Growth Factor Receptors (EGFR). Preliminary results suggest that the drug could kill cancer cells that are not killed by other breast cancer drugs. Dr F. Cardoso from the Jules Bordet Institute, Brussels, who is involved in the drug research said, "Raloxifene and lapatinib are exciting new drugs which will be of interest in prevention and treatment of breast cancer patients in the future." Contact: EBCC-5 Press Office stephanie.makin@toniclc.com 33-493-928-402 Federation of European Cancer Societies Source: Eurekalert
'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
(Date:6/23/2016)... June 23, 2016 The vast majority of ... dialysis facility.  Treatments are usually 3 times a week, ... visit, including travel time, equipment preparation and wait time. ... especially grueling for patients who are elderly and frail.  ... nursing and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: